Biopsy on way to dustbin as blood test to determine cancer
Biopsies may become dated before long. Blood tests will be sufficient to find a tumor in human bodies in the coming days, making it look a lot easier and less time consuming than any time in the past.
Usually in case of cancer biopsy, a piece of the tumor of patient is taken out by doctors to determine the cancerous tumor. But if researchers are to be believed, biopsy will not be needed any more and that a simple blood test will be able to ascertain this fact.
Researchers claim that a blood test is all that may be needed in locating tiny snippets of cancer DNA in a patient’s blood. The researchers are hopeful that this blood test will allow oncologists to immediately figure out regardless of whether a treatment is operating and, if so, to closely monitor the remedy if resistance is developed by cancer.
While talking about the findings of the study Dr. Jose Baselga, physician in chief and chief healthcare officer at Memorial Sloan Kettering Cancer Center in New York says, â€œThis could transform forever the way we stick to up not only response to treatments but also the emergence of resistance, and down the line could even be employed for definitely early diagnosisâ€. The researchers, however, said that much more evaluations of the accuracy and reliability of the test should be done. They added that only compact studies have been done in unique cancers, which includes lung, colon and blood cancer. But early final results are without encouraging.
Earlier this month the National Cancer Institute published a report detailing the findings in The Lancet Oncology. For the study, the researchers involved 126 patients with the most frequent kind of lymphoma identified the test predicted recurrences a lot more than three months prior to they have been noticeable on CT scans. The liquid biopsies also identified individuals who are unlikely to show any response to therapy. â€œEvery cancer has a mutation that can be followed with this system,” said Dr. David Hyman, an oncologist at Sloan Kettering. “It is like bar coding the cancer in the blood.â€